Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: March 24, 2022
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2),
which
causes
coronavirus-19
(COVID-19),
has
caused
significant
morbidity
and
mortality
globally.
In
addition
to
the
respiratory
manifestations
seen
in
severe
cases,
multi-organ
pathologies
also
occur,
making
management
a
much-debated
issue.
addition,
emergence
of
new
variants
can
potentially
render
vaccines
with
relatively
limited
utility.
Many
investigators
have
attempted
elucidate
precise
pathophysiological
mechanisms
causing
COVID-19
systemic
disease.
Spillover
lung-derived
cytokines
cytokine
storm
is
considered
cause
However,
recent
studies
provided
contradictory
evidence,
whereby
extent
insufficient
illness.
These
issues
are
highly
relevant,
as
approaches
considering
classic
form
acute
distress
syndrome
could
translate
unfounded
clinical
decisions,
detrimental
patient
trajectory.
Additionally,
immune
cell
signatures
that
characterize
disease
varying
severity
remain
contentious.
We
provide
an
up-to-date
review
on
dysregulation
by
highlight
pertinent
discussions
scientific
community.
The
response
from
community
been
unprecedented
regarding
development
effective
cutting-edge
research
novel
therapies.
hope
this
furthers
conversations
held
scientists
informs
aims
future
projects,
will
further
our
understanding
its
pathogenesis.
Nature Medicine,
Journal Year:
2021,
Volume and Issue:
28(1), P. 201 - 211
Published: Nov. 15, 2021
Abstract
Although
critical
for
host
defense,
innate
immune
cells
are
also
pathologic
drivers
of
acute
respiratory
distress
syndrome
(ARDS).
Innate
dynamics
during
Coronavirus
Disease
2019
(COVID-19)
ARDS,
compared
to
ARDS
from
other
pathogens,
is
unclear.
Moreover,
mechanisms
underlying
the
beneficial
effects
dexamethasone
severe
COVID-19
remain
elusive.
Using
single-cell
RNA
sequencing
and
plasma
proteomics,
we
discovered
that,
bacterial
was
associated
with
expansion
distinct
neutrophil
states
characterized
by
interferon
(IFN)
prostaglandin
signaling.
Dexamethasone
affected
circulating
neutrophils,
altered
IFN
active
downregulated
interferon-stimulated
genes
activated
IL-1R2
+
neutrophils.
expanded
immunosuppressive
immature
neutrophils
remodeled
cellular
interactions
changing
information
receivers
into
providers.
Male
patients
had
higher
proportions
preferential
steroid-induced
expansion,
potentially
affecting
outcomes.
Our
atlas
(see
‘Data
availability’
section)
defines
COVID-19-enriched
molecular
action
develop
targeted
immunotherapies
COVID-19.
Science Immunology,
Journal Year:
2022,
Volume and Issue:
7(67)
Published: Jan. 7, 2022
Coronavirus
disease
2019
(COVID-19)
is
a
characterized
by
profound
dysregulation
of
the
innate
immune
system.
This
knowledge
has
emerged
from
large
body
single-cell
omics
studies
patients
with
COVID-19,
which
have
provided
one
most
detailed
cellular
atlases
human
ever.
However,
we
are
only
beginning
to
understand
immunological
pathways
that
govern
host
defense
and
immunopathology
in
COVID-19.
In
this
review,
discuss
emerging
understanding
how
SARS-CoV-2
host-derived
molecules
activate
specific
pattern
recognition
receptors
elicit
protective
interferon
responses
pathological
cytokine
responses,
particular
focus
on
acute
infection
lung
pathophysiology
critical
addition,
these
modulated
virus-host
interactions
stress-sensing
pathways.
In-depth
mechanisms
will
likely
uncover
molecular
targets
for
treatment
COVID-19
other
viral
infections.
it
reveal
fine
balance
between
beneficial
versus
causing
responses.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: July 29, 2022
Acute
lung
injury
(ALI)
is
a
heterogeneous
inflammatory
condition
associated
with
high
morbidity
and
mortality.
Neutrophils
play
key
role
in
the
development
of
different
forms
ALI,
release
neutrophil
extracellular
traps
(NETs)
emerging
as
common
pathogenic
mechanism.
NETs
are
essential
controlling
pathogens,
their
defective
or
increased
degradation
leads
to
higher
risk
infection.
However,
also
contain
several
pro-inflammatory
cytotoxic
molecules
than
can
exacerbate
thromboinflammation
tissue
injury.
To
reduce
NET-mediated
damage
inflammation,
DNase
frequently
used
preclinical
models
ALI
due
its
capability
digesting
NET
DNA
scaffold.
Moreover,
recent
advances
biology
led
selective
inhibitors,
which
appear
experimental
models.
Here
we
provide
an
overview
discussing
existing
gaps
our
knowledge
novel
therapeutic
approaches
modulate
impact
on
Science Immunology,
Journal Year:
2023,
Volume and Issue:
8(80)
Published: Feb. 3, 2023
Neutrophils,
the
most
abundant
innate
immune
cells,
function
as
crucial
regulators
of
adaptive
system
in
diverse
pathological
conditions,
including
metastatic
cancer.
However,
it
remains
largely
unknown
whether
their
immunomodulatory
functions
are
intrinsic
or
acquired
within
tissue
environment.
Here,
using
mouse
models
breast
cancer
lungs,
we
show
that,
although
neutrophils
isolated
from
bone
marrow
(BM)
blood
minimally
immunosuppressive,
lung-infiltrating
robustly
suppressive
both
T
cells
and
natural
killer
(NK)
cells.
We
found
that
this
tissue-specific
immunosuppressive
capacity
exists
steady
state
is
reinforced
by
tumor-associated
inflammation.
Acquisition
potent
immunosuppression
activity
was
endowed
lung-resident
stroma,
specifically
CD140a
+
mesenchymal
(MCs)
via
prostaglandin-endoperoxide
synthase
2
(PTGS2),
rate-limiting
enzyme
for
prostaglandin
E
(PGE
)
biosynthesis.
MC-specific
deletion
Ptgs2
pharmacological
inhibition
PGE
receptors
reversed
lung
neutrophil–mediated
mitigated
metastasis
vivo.
These
stroma–targeting
strategies
substantially
improved
therapeutic
efficacy
adoptive
cell–based
immunotherapy
treating
disease
mice.
Collectively,
our
results
reveal
immunoregulatory
effects
induced
tissue-resident
stroma
targeting
stromal
factors
represents
an
effective
approach
to
boost
immunity
against
disease.
Virology Journal,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Aug. 2, 2023
Abstract
Coronavirus
disease
2019
(COVID-19)
is
an
acute
respiratory
caused
by
severe
syndrome
coronavirus
2
(SARS-CoV-2),
which
can
lead
to
distress
(ARDS),
multi-organ
failure
and
death,
posing
significant
threat
human
health.
Studies
have
found
that
pathological
mechanisms,
such
as
cytokine
storms
uncontrolled
innate
immune
system
activation,
release
of
damage-associated
molecular
patterns
during
tissue
injury
a
high
incidence
thrombotic
events,
are
associated
with
the
function
dysfunction
neutrophils.
Specifically,
increased
formation
low-density
neutrophils
(LDNs)
neutrophil
extracellular
traps
(NETs)
has
been
shown
be
closely
linked
severity
poor
prognosis
in
patients
COVID-19.
Our
work
focuses
on
understanding
number,
abnormal
lung
infiltration,
elevated
neutrophil-to-lymphocyte
ratio
pathogenesis
We
also
explore
involvement
NETs
LDNs
progression
thrombosis
formation,
along
potential
therapeutic
strategies
targeting
formation.
Immunity & Ageing,
Journal Year:
2022,
Volume and Issue:
19(1)
Published: Nov. 11, 2022
Abstract
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
infectious
caused
by
the
novel
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2).
COVID-19
characterized
having
heterogeneous
course,
ranging
from
asymptomatic
and
mild
symptoms
to
more
critical
cases.
In
most
cases
severity
of
related
host
factors,
especially
deregulation
immune
response
in
patients.
Even
if
indiscriminately
affects
individuals
different
age
group,
ethnicity
economic
status;
disproportional
mortality
occur
elderly
individuals.
This
point
out
that
aging
one
risk
factor
for
unfavourable
clinical
outcomes
among
The
biology
complex
process;
Aging
can
alter
structure
function
cells,
tissues,
organs
resulting
impaired
stress.
Alongside
with
other
systems,
system
also
affected
process.
Immunosenescence
an
associated
change
overall
immunological
challenges
elderly.
Similarly,
apart
normal
inflammatory
process,
low
grade,
sterile,
chronic
inflammation
which
termed
as
inflammaging.
We
hypothesized
inflammaging
immunosenescence
could
play
important
role
SARS-CoV-2
pathogenesis
poor
recovery
review
summarizes
changes
how
these
part
outcome
add
understanding
targeted
immunotherapy
Allergy,
Journal Year:
2022,
Volume and Issue:
77(8), P. 2415 - 2430
Published: April 1, 2022
Several
autoimmune
features
occur
during
coronavirus
disease
2019
(COVID-19),
with
possible
implications
for
course,
immunity,
and
pathology.
In
this
study,
we
longitudinally
screened
clinically
relevant
systemic
autoantibodies
to
assess
their
prevalence,
temporal
trajectory,
association
comorbidities,
severity
of
COVID-19.We
performed
highly
sensitive
indirect
immunofluorescence
assays
detect
antinuclear
antibodies
(ANA)
antineutrophil
cytoplasmic
(ANCA),
along
serum
proteomics
virome-wide
serological
profiling
in
a
multicentric
cohort
175
COVID-19
patients
followed
up
1
year
after
infection,
eleven
vaccinated
individuals,
41
unexposed
controls.Compared
healthy
controls,
similar
prevalence
patterns
ANA
were
present
acute
recovery.
However,
the
paired
analysis
revealed
subgroup
transient
presence
certain
COVID-19.
Furthermore,
severe
exhibited
high
ANCA
disease.
These
quantitatively
associated
higher
SARS-CoV-2-specific
antibody
titers
thus
linking
autoantibody
production
increased
antigen-specific
humoral
responses.
Notably,
qualitative
breadth
cross-reactive
other
coronaviruses
was
comparable
ANA-positive
ANA-negative
individuals
autoantibody-positive
patients,
multiparametric
characterization
demonstrated
an
inflammatory
signature
alterations
B-cell
compartment
recovery.Highly
SARS-CoV-2
while
correlated
antiviral
immune
responses
signatures.
Cell Reports Medicine,
Journal Year:
2022,
Volume and Issue:
3(10), P. 100779 - 100779
Published: Sept. 26, 2022
Mechanisms
of
neutrophil
involvement
in
severe
coronavirus
disease
2019
(COVID-19)
remain
incompletely
understood.
Here,
we
collect
longitudinal
blood
samples
from
306
hospitalized
COVID-19+
patients
and
86
controls
perform
bulk
RNA
sequencing
enriched
neutrophils,
plasma
proteomics,
high-throughput
antibody
profiling
to
investigate
relationships
between
states
severity.
We
identify
dynamic
switches
six
distinct
subtypes.
At
days
3
7
post-hospitalization,
with
display
a
granulocytic
myeloid-derived
suppressor
cell-like
gene
expression
signature,
while
resolving
show
progenitor-like
signature.
Humoral
responses
are
identified
as
potential
drivers
effector
functions,
elevated
acute
respiratory
syndrome
2
(SARS-CoV-2)-specific
immunoglobulin
G1
(IgG1)-to-IgA1
ratios
who
survived.
In
vitro
experiments
confirm
that
patient-derived
IgG
antibodies
induce
phagocytosis
healthy
donor
IgA
predominantly
cell
death.
Overall,
our
study
demonstrates
dysregulated
myelopoietic
response
COVID-19
role
for
IgA-dominant
contributing
mortality.
Biochemical Journal,
Journal Year:
2022,
Volume and Issue:
479(5), P. 609 - 628
Published: March 4, 2022
Two
years
after
the
emergence
of
SARS-CoV-2,
our
understanding
COVID-19
disease
pathogenesis
is
still
incomplete.
Despite
unprecedented
global
collaborative
scientific
efforts
and
rapid
vaccine
development,
an
uneven
roll-out
novel
variants
concern
such
as
omicron
underscore
critical
importance
identifying
mechanisms
that
contribute
to
this
disease.
Overt
inflammation
cell
death
have
been
proposed
be
central
drivers
severe
pathology
in
patients
their
pathways
molecular
components
therefore
present
promising
targets
for
host-directed
therapeutics.
In
review,
we
summarize
current
knowledge
on
role
impact
diverse
programmed
(PCD)
We
dissect
complex
connection
inflammatory
signaling
at
cellular
level
identify
a
number
questions
remain
addressed.
provide
rationale
targeting
potential
treatment
overview
therapeutics
could
potentially
enter
clinical
trials
near
future.